Trials / Not Yet Recruiting
Not Yet RecruitingNCT07139535
A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of RAY1225 Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 350 (estimated)
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal for this study is to evaluate the efficacy and safety of RAY1225 versus placebo in participants with type 2 diabetes not under control with diet and exercise alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RAY1225 | Administered SC |
| DRUG | placebo | Administered SC |
Timeline
- Start date
- 2025-08-31
- Primary completion
- 2026-12-01
- Completion
- 2026-12-31
- First posted
- 2025-08-24
- Last updated
- 2025-08-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07139535. Inclusion in this directory is not an endorsement.